XBIOTECH INC. Unrecognized Tax Benefits, Period Increase (Decrease)
XBIOTECH INC. (XBIT) reported Unrecognized Tax Benefits, Period Increase (Decrease) of $14.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2022-05-10
- XBIOTECH INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2022-03-31 was $14.00K.
- XBIOTECH INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2021-09-30 was $0.00.
- XBIOTECH INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2021-06-30 was $271.00K.
- XBIOTECH INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2021-03-31 was $0.00.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 6 month | Unrecognized Tax Benefits, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2022-03-31 | $14.00K 10-Q · filed 2022-05-10 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $271.00K derived: sum of 2 quarters · filed 2021-11-09 | $271.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $271.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $271.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |